Dr. James L. Sherley M.D., Ph.D. ,Senior Scientist Programs in Regenerative Biology and Cancer at the Boston Biomedical Research Institute, discusses why Embryonic Stem Cell Research will fail from a biological perspective. WWW.BBRI.ORG
MARLBOROUGH, Mass. – Feb. 23, 2011. Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that it has been issued a patent on its “single-blastomere” technique. Patent Number 7,893,315 broadly covers ACT’s proprietary single-blastomere technology that provides a non-destructive alternative for deriving human embryonic stem cell (hESC) lines
Sherley is an unequivocal case of a person putting a label/a title on his breast pocket MOSTLY ONLY so he would be allowed, to vanishingly great degrees, to be complete stupid. This is what happens when someone decides to skip introductory logic in college as a fun, informative, & exploratory course (& was forced later to complete it as a mere prerequisite for something else and likely hated it and thus never truly grasp much of its usefullness in every day life).
As I said last week BBRI and the NIH should take a VERY close look at Sherley's so called adult stem cell expertise and work. This guy is very mediocre if he were a first rate scientist he would have been tenured at MIT. Instead MIT threw him out during tenure review because he likely didn't meet their minimal standards. You are running out of cards to play...
Recently, Dr. James Sherley, a BBRI investigator, commenced a civil action against NIH seeking to prohibit its funding of human embryonic stem cell research. While BBRI recognizes that Dr. Sherley has the legal right to pursue this course of action on his own behalf, BBRI is not in any way participating in Dr. Sherley's actions. Dr. Sherley's position on this issue neither represents nor reflects that of BBRI.
Why Dr. James Sherley will fail "Although Dr. Sherley has also submitted five grant applications that were not awarded (in addition to those grant applications that were awarded), this denial of funds was in no way attributable to the Guidelines or competition from hESC researchers. Rather, it was the result of the failure of his projects to clear peer review on the basis of scientific merit, a prerequisite to eligibility for funding. Dr. Collins Decl. ¶ 23.
"The likelihood of harm to Dr. Deisher as a result of the stay approaches the vanishing point. As far as NIH is aware, Dr. Deisher has never made a single application for the funding for which she claims increased competition."
The two doctor's "remote economic self-interests do not outweigh the harm the injunction will cause NIH, the hundreds of affected human embryonic stem cell researchers, and the millions of individuals who hold out hope that human embryonic stem cell research will lead to the cure for, or treatment of, their currently incurable illnesses," the Justice Department said.
MARLBOROUGH, Mass. – Feb. 23, 2011. Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that it has been issued a patent on its “single-blastomere” technique. Patent Number 7,893,315 broadly covers ACT’s proprietary single-blastomere technology that provides a non-destructive alternative for deriving human embryonic stem cell (hESC) lines
gman7111 11 months ago
Sherley is an unequivocal case of a person putting a label/a title on his breast pocket MOSTLY ONLY so he would be allowed, to vanishingly great degrees, to be complete stupid. This is what happens when someone decides to skip introductory logic in college as a fun, informative, & exploratory course (& was forced later to complete it as a mere prerequisite for something else and likely hated it and thus never truly grasp much of its usefullness in every day life).
HenryDavidT 1 year ago
As I said last week BBRI and the NIH should take a VERY close look at Sherley's so called adult stem cell expertise and work. This guy is very mediocre if he were a first rate scientist he would have been tenured at MIT. Instead MIT threw him out during tenure review because he likely didn't meet their minimal standards. You are running out of cards to play...
gman7111 1 year ago
Newsalert: COURT SUSPENDS BAN ON EMBRYONIC STEM CELL RESEARCH
gman7111 1 year ago
Recently, Dr. James Sherley, a BBRI investigator, commenced a civil action against NIH seeking to prohibit its funding of human embryonic stem cell research. While BBRI recognizes that Dr. Sherley has the legal right to pursue this course of action on his own behalf, BBRI is not in any way participating in Dr. Sherley's actions. Dr. Sherley's position on this issue neither represents nor reflects that of BBRI.
gman7111 1 year ago
Why Dr. James Sherley will fail "Although Dr. Sherley has also submitted five grant applications that were not awarded (in addition to those grant applications that were awarded), this denial of funds was in no way attributable to the Guidelines or competition from hESC researchers. Rather, it was the result of the failure of his projects to clear peer review on the basis of scientific merit, a prerequisite to eligibility for funding. Dr. Collins Decl. ¶ 23.
gman7111 1 year ago
"The likelihood of harm to Dr. Deisher as a result of the stay approaches the vanishing point. As far as NIH is aware, Dr. Deisher has never made a single application for the funding for which she claims increased competition."
gman7111 1 year ago
Eugenics will eventually take care of slime like this...
gman7111 1 year ago
The two doctor's "remote economic self-interests do not outweigh the harm the injunction will cause NIH, the hundreds of affected human embryonic stem cell researchers, and the millions of individuals who hold out hope that human embryonic stem cell research will lead to the cure for, or treatment of, their currently incurable illnesses," the Justice Department said.
gman7111 1 year ago
@matcotech Embryonic stem cells haven't cured anything yet! trials have failed
marineninga 1 year ago